Drug of the week series: 20.2

A 48-year-old patient with type 2 diabetes mellitus has diabetic dyslipidemia with elevated triglycerides despite statin therapy. Which of the following is the most appropriate clinical use of saroglitazar?

  • A. Treatment of Diabetic Ketoacidosis
  • B. Management of diabetic dyslipidemia, particularly hypertriglyceridemia
  • C. First-line treatment of type 1 diabetes mellitus
  • D. Treatment of acute hypercholesterolemia
0 voters

MBH/PS

Saroglitazar is a dual PPAR- Alpha/ gamma agonist indicated only for diabetic patients with dyslipidemia despite being on statins.

1 Like